Delivery Order SPE2DB22D1106-SPE2DB25FFDN4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,615.05 to AmerisourceBergen Drug Corp for Corlanor 7.5 mg tablets (60-count units) on August 5, 2025, with completion expected by August 6, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $9,479.97 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Corlanor 5 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by July 29, 2025. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Corlanor 7.5 mg tablets (60-count units) at a firm fixed price of $1,165.23. This non-set-aside delivery order represents a child contract vehicle under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract utilizes a firm fixed-price structure and is scheduled for ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Corlanor 5 mg tablets (60-count) with a ceiling value of $3,296.56. This firm fixed price delivery order, with an ultimate completion date of August 13, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was...
- The Defense Logistics Agency awarded a delivery order valued at $1,642.24 to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The contract represents a routine pharmaceutical procurement supporting federal medical supply needs...
- The Defense Logistics Agency awarded a $1,137 delivery order to Amerisourcebergen Drug Corporation for 4562195687 Corlanor 5 MG tablets. Under this firm fixed price contract, Amerisourcebergen will provide 60 tablets of the specified medication to an address in Conshohocken, Pennsylvania, with performance required between September 15-18, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen frequently receives such small dollar,...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical for $3,141.18. Under this order, the company will supply 60 tablets of Corlanor 5 mg to support DLA's provision of pharmaceuticals and critical care supplies for military treatment programs. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by December...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Corlanor 5 mg tablets. The contract has a ceiling value of $5,070.39 and is a firm fixed-price delivery order without any set-aside designation, indicating open competition. The contract has an ultimate completion date of May 2, 2025 and was awarded on May 1, 2025. AmerisourceBergen Drug Corp, based in...
- The Defense Logistics Agency awarded a $3,310.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, with an ultimate completion date of August 18, 2025. This non-set-aside contract was competitively awarded on August 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,809.83, is for the supply of 4,568,108,411 units of the medication Corlanor 5 mg tablet. The contract has an ultimate completion date of May 2, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFDN4Delivery Order
The Defense Logistics Agency awarded a $1,549.52 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Corlanor 5 mg tablets (60-count). This is a non-set-aside contract with an ultimate completion date of August 18, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The pharmaceutical will be delivered to the company's corporate office location in Conshohocken, PA. This delivery order is executed under AmerisourceBergen's comprehensive $999.99 billion Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and enables the company to supply a broad portfolio of pharmaceutical products and medical supplies to military healthcare programs globally. The contract reflects AmerisourceBergen's competitive standing in the federal pharmaceutical supply market and its role within the DLA's Medical Supply Chain supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/15/25 |